دورية أكاديمية
The impact of kidney stone disease on quality of life in high-risk stone formers.
| العنوان: | The impact of kidney stone disease on quality of life in high-risk stone formers. |
|---|---|
| المؤلفون: | Assad A; Division of Urology, Centre Hospitalier de l'Université de Montréal, Montréal, Quebec, Canada., Raizenne BL; Division of Urology, Centre Hospitalier de l'Université de Montréal, Montréal, Quebec, Canada., El Yamani MEM; Division of Urology, Centre Hospitalier de l'Université de Montréal, Montréal, Quebec, Canada., Saud A; Division of Urology, Centre Hospitalier de l'Université de Montréal, Montréal, Quebec, Canada., Bechis SK; Department of Urology, University of California San Diego, San Diego, CA, USA., Sur RL; Department of Urology, University of California San Diego, San Diego, CA, USA., Nakada SY; Department of Urology, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA., Streeper NM; Department of Urology, Pennsylvania State University College of Medicine, Hershey, PA, USA., Sivalingam S; Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH, USA., Pais VM Jr; Urology Section, Dartmouth Hitchcock Medical Center, Lebanon, NH, USA., Chew BH; Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada., Bird VG; Department of Urology, University of Florida College of Medicine, Gainesville, FL, USA., Andonian S; Division of Urology, McGill University Health Center, Montreal, Quebec, Canada., Penniston KL; Department of Urology, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA., Bhojani N; Division of Urology, Centre Hospitalier de l'Université de Montréal, Montréal, Quebec, Canada. |
| المصدر: | BJU international [BJU Int] 2024 May; Vol. 133 (5), pp. 570-578. Date of Electronic Publication: 2024 Feb 08. |
| نوع المنشور: | Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't |
| اللغة: | English |
| بيانات الدورية: | Publisher: Blackwell Science Country of Publication: England NLM ID: 100886721 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1464-410X (Electronic) Linking ISSN: 14644096 NLM ISO Abbreviation: BJU Int Subsets: MEDLINE |
| أسماء مطبوعة: | Original Publication: Oxford, UK : Blackwell Science, c1999- |
| مواضيع طبية MeSH: | Quality of Life* , Kidney Calculi*/complications, Humans ; Female ; Male ; Middle Aged ; Adult ; Aged ; Acidosis, Renal Tubular/complications ; Medullary Sponge Kidney/complications ; Surveys and Questionnaires |
| مستخلص: | Objective: To assess the impact of kidney stone disease (KSD) and its treatment on the health-related quality of life (HRQOL) of high-risk stone formers with hyperparathyroidism, renal tubular acidosis, malabsorptive disease, and medullary sponge kidney. Patients and Methods: The Wisconsin Stone Quality of Life questionnaire was used to evaluate HRQOL in 3301 patients with a history of KSD from 16 institutions in North America between 2014 and 2020. Baseline characteristics and medical history were collected from patients, while active KSD was confirmed through radiological imaging. The high-risk group was compared to the remaining patients (control group) using the Wilcoxon rank-sum test. Results: Of 1499 patients with active KSD included in the study, the high-risk group included 120 patients. The high-risk group had significantly lower HRQOL scores compared to the control group (P < 0.01). In the multivariable analyses, medullary sponge kidney disease and renal tubular acidosis were independent predictors of poorer HRQOL, while alkali therapy was an independent predictor of better HRQOL (all P < 0.01). Conclusions: Among patients with active KSD, high-risk stone formers had impaired HRQOL with medullary sponge kidney disease and renal tubular acidosis being independent predictors of poorer HRQOL. Clinicians should seek to identify these patients earlier as they would benefit from prompt treatment and prevention. (© 2024 The Authors. BJU International published by John Wiley & Sons Ltd on behalf of BJU International.) |
| References: | Chen Z, Prosperi M, Bird VY. Prevalence of kidney stones in the USA: the National Health and nutrition evaluation survey. J Clin Urol 2019; 12: 296–302. Howles SA, Thakker RV. Genetics of kidney stone disease. Nat Rev Urol 2020; 17: 407–421. Türk C, Petřík A, Sarica K et al. EAU guidelines on diagnosis and conservative management of urolithiasis. Eur Urol 2016; 69: 468–474. Pearle MS, Goldfarb DS, Assimos DG et al. Medical management of kidney stones: AUA guideline. J Urol 2014; 192: 316–324. Bhojani N, Bjazevic J, Wallace B et al. UPDATE – Canadian Urological Association guideline: evaluation and medical management of kidney stones. CUAJ 2022; 16: 175–188. New F, Somani BK. A complete world literature review of quality of life (QOL) in patients with kidney stone disease (KSD). Curr Urol Rep 2016; 17: 88. Cicerello E, Ciaccia M, Cova G, Mangano M. The impact of potassium citrate therapy in the natural course of medullary sponge kidney with associated nephrolithiasis. Arch Ital Urol Androl 2019; 91: 102–106. Kartha G, Calle JC, Marchini GS, Monga M. Impact of stone disease: chronic kidney disease and quality of life. Urol Clin North Am 2013; 40: 135–147. Bhojani N, Moussaoui G, Nguyen DD et al. Validation of the French version of the Wisconsin quality of life (WISQOL) questionnaire for patients with nephrolithiasis. Can Urol Assoc J 2021; 15: E227–E231. Streeper NM, Wertheim ML, Nakada SY, Penniston KL. Cystine stone formers have impaired health‐related quality of life compared with noncystine stone formers: a case‐referent study piloting the Wisconsin stone quality of life questionnaire among patients with cystine stones. J Endourol 2017; 31(S1): S48–S53. Lim JRZ, Scotland KB, Bechis SK et al. Metabolic syndrome negatively impacts stone‐specific quality of life. J Endourol 2020; 34: 1203–1208. Raizenne BL, Deyirmendjian C, Bechis SK et al. The duration of stone disease and the impact of a stone event on Patients' quality of life. J Endourol 2022; 36: 1371–1376. Ahlstrand C, Tiselius HG. Recurrences during a 10‐year follow‐up after first renal stone episode. Urol Res 1990; 18: 397–399. Bensalah K, Tuncel A, Gupta A, Raman JD, Pearle MS, Lotan Y. Determinants of quality of life for patients with kidney stones. J Urol 2008; 179: 2238–2243 discussion 2243. Khan SR, Pearle MS, Robertson WG et al. Kidney stones. Nat Rev Dis Primers 2016; 2: 16008. Penniston KL, Sninsky BC, Nakada SY. Preliminary evidence of decreased disease‐specific health‐related quality of life in asymptomatic stone patients. J Endourol 2016; 30(Suppl 1): S42–S45. Bryant M, Angell J, Tu H, Goodman M, Pattaras J, Ogan K. Health related quality of life for stone formers. J Urol 2012; 188: 436–440. Sharadin C, Lowry P. Health‐related quality of life and urolithiasis. In Lowry P, Penniston KL eds, Nutrition therapy for urolithiasis. Cham, Switzerland: Springer International Publishing, 2018: 17–27. Arafa MA, Rabah DM. Study of quality of life and its determinants in patients after urinary stone fragmentation. Health Qual Life Outcomes 2010; 8: 119. Hamamoto S, Unno R, Taguchi K et al. Determinants of health‐related quality of life for patients after urinary lithotripsy: ureteroscopic vs. shock wave lithotripsy. Urolithiasis 2018; 46: 203–210. Raja A, Hekmati Z, Joshi HB. How do urinary calculi influence health‐related quality of life and patient treatment preference: a systematic review. J Endourol 2016; 30: 727–743. Fann CY, Huang PC, Yen AMF, Chen HH. Patient utility measurement for managing ureteral stones: a modified standard gamble approach. Value Health Reg Issues 2012; 1: 87–92. Mays NB, Petruckevitch A, Snowdon C. Patients' quality of life following extracorporeal shock‐wave lithotripsy and percutaneous nephrolithotomy for renal calculi. Int J Technol Assess Health Care 1990; 6: 633–642. Kuo RL, Aslan P, Abrahamse PH, Matchar DB, Preminger GM. Incorporation of patient preferences in the treatment of upper urinary tract calculi: a decision analytical view. J Urol 1999; 162: 1913–1918 discussion 1918‐9. Kurahashi T, Miyake H, Shinozaki M et al. Health‐related quality of life in patients undergoing lithotripsy for urinary stones. Int Urol Nephrol 2008; 40: 39–43. Raffin EP, Penniston KL, Antonelli JA et al. The effect of thiazide and potassium citrate use on the health related quality of life of patients with urolithiasis. J Urol 2018; 200: 1290–1294. Bensalah K, Tuncel A, Raman JD, Bagrodia A, Pearle M, Lotan Y. How physician and patient perceptions differ regarding medical management of stone disease. J Urol 2009; 182: 998–1004. Mehmi A, Jones P, Somani BK. Current status and role of patient‐reported outcome measures (PROMs) in endourology. Urology 2021; 148: 26–31. Penniston KL, Nakada SY. Treatment expectations and health‐related quality of life in stone formers. Curr Opin Urol 2016; 26: 50–55. Joshi HB, Johnson H, Pietropaolo A et al. Urinary stones and intervention quality of life (USIQoL): development and validation of a new core universal patient‐reported outcome measure for urinary calculi. Eur Urol Focus 2022; 8: 283–290. |
| فهرسة مساهمة: | Keywords: endourology; hyperparathyroidism; kidney stone; malabsorption; medullary sponge kidney; quality of life; renal tubular acidosis |
| تواريخ الأحداث: | Date Created: 20240209 Date Completed: 20240423 Latest Revision: 20240508 |
| رمز التحديث: | 20240508 |
| DOI: | 10.1111/bju.16294 |
| PMID: | 38332669 |
| قاعدة البيانات: | MEDLINE |
Full Text Finder كن أول من يترك تعليقا!